| Title |
Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells
|
|---|---|
| Published in |
Journal for Immunotherapy of Cancer, December 2018
|
| DOI | 10.1186/s40425-018-0441-8 |
| Pubmed ID | |
| Authors |
Jiao Wang, Kyle B. Lupo, Andrea M. Chambers, Sandro Matosevic |
X Demographics
The data shown below were collected from the profiles of 27 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 15% |
| Spain | 2 | 7% |
| Italy | 1 | 4% |
| Turkey | 1 | 4% |
| Japan | 1 | 4% |
| Singapore | 1 | 4% |
| Russia | 1 | 4% |
| India | 1 | 4% |
| Chile | 1 | 4% |
| Other | 1 | 4% |
| Unknown | 13 | 48% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 16 | 59% |
| Scientists | 5 | 19% |
| Practitioners (doctors, other healthcare professionals) | 3 | 11% |
| Science communicators (journalists, bloggers, editors) | 3 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 111 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 17 | 15% |
| Student > Ph. D. Student | 16 | 14% |
| Student > Master | 15 | 14% |
| Student > Bachelor | 8 | 7% |
| Other | 7 | 6% |
| Other | 11 | 10% |
| Unknown | 37 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 19 | 17% |
| Immunology and Microbiology | 16 | 14% |
| Medicine and Dentistry | 7 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 5% |
| Agricultural and Biological Sciences | 6 | 5% |
| Other | 13 | 12% |
| Unknown | 44 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 April 2021.
All research outputs
#1,537,251
of 25,809,966 outputs
Outputs from Journal for Immunotherapy of Cancer
#392
of 3,482 outputs
Outputs of similar age
#34,326
of 449,596 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#11
of 63 outputs
Altmetric has tracked 25,809,966 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,482 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.7. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,596 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 63 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.